The quick answer
A GLP-1 tracker app is the easiest way to manage Mounjaro's weekly rhythm. DoseDash reminds you on dose day, records injection sites, charts an estimated tirzepatide level between shots and links side effects to your escalation steps — free on iPhone.
How DoseDash helps with Mounjaro
- Weekly dose-day countdown and reminders
- Estimated medication-level chart based on tirzepatide's published half-life
- Body-map injection site tracking with rotation suggestions
- AI insights that connect doses, meals and how you feel each week
What if you miss a Mounjaro dose?
Per the official prescribing information: if you miss a Mounjaro dose, take it as soon as possible within 4 days (96 hours). If more than 4 days have passed, skip the missed dose and take your next dose on the regularly scheduled day. Don't double up — and check with your prescriber if you're unsure.
Official source: mounjaro.comTypical Mounjaro dose schedule
| Dose | When |
|---|---|
| 2.5 mg | Weeks 1–4 (starter dose) |
| 5 mg | Weeks 5–8 |
| 7.5–15 mg | If needed, in 2.5 mg steps every 4+ weeks (15 mg max) |
Typical escalation from the official label — increases come in 2.5 mg steps at least 4 weeks apart. Your prescriber sets your actual plan.
Taking Mounjaro: the basics
- Injected under the skin in the abdomen, thigh or upper arm
- Rotate injection sites with each dose
- Same day each week, any time of day, with or without meals
- Single-dose pens — store in the fridge per the label
Start tracking Mounjaro in 3 steps
- 1Download DoseDash free on the App Store and pick Mounjaro from 30+ supported GLP-1 medications.
- 2Set your dose day and current dose — reminders and the level chart configure themselves.
- 3Log each dose in one tap, add side effects and meals as they happen, and watch your trends build within the first week.
Why not just use a notes app?
Notes capture what happened; a tracker shows what it means. Where a note says “injected Tuesday, felt queasy Thursday,” DoseDash charts the estimated tirzepatide level between doses, lines your side effects up against it, reminds you before your next dose is due, and turns months of entries into a report your care team can read in seconds.
Mounjaro tracking FAQ
Is there a free app to track Mounjaro?
Yes — DoseDash is free to download on the App Store, with dose logging, reminders, injection-site tracking and side-effect trends included.
What if I miss my Mounjaro dose?
Officially, take it within 4 days (96 hours) of the missed dose; after that, skip and resume your normal schedule. DoseDash shows exactly how long it's been since your last shot, so the 4-day window is never a guess.
How long does Mounjaro stay in your system?
Tirzepatide's half-life is about 5 days, so it takes roughly 4 weeks after stopping to largely clear. DoseDash's level chart visualizes the estimated curve between your weekly doses.
Where should I inject Mounjaro?
Under the skin of the abdomen, thigh or upper arm, rotating sites each week. DoseDash's body map records every injection and suggests the next site.
Does DoseDash support Mounjaro's dose strengths?
All of them — 2.5 through 15 mg. Update your dose at each escalation step and your reminders, history and charts follow along.
Can I track Mounjaro side effects by dose?
Yes. Log symptoms with severity ratings and DoseDash charts them against your dose history, which makes escalation-related patterns easy to spot and easy to show your care team.
DoseDash is a tracking and educational tool — not medical advice. Mounjaro® is a trademark of its owner; DoseDash is not affiliated with, endorsed by or sponsored by Eli Lilly or any pharmaceutical company. Dosing information above summarizes publicly available prescribing information and may change — always follow the guidance of your prescriber and care team.
Last updated: 2026-08-26
Start your Mounjaro journey with DoseDash
Helpful guides
- Missed a GLP-1 dose? Rules for every medication
- GLP-1 injection sites & rotation
- Managing GLP-1 nausea & side effects
- GLP-1 medications compared
- Helping a partner or parent track their GLP-1


